M. Glauser

发表

Quinupristin-Dalfopristin Combined with β-Lactams for Treatment of Experimental Endocarditis Due to Staphylococcus aureus Constitutively Resistant to Macrolide-Lincosamide-Streptogramin B Antibiotics

P. Moreillon, J. Entenza, J. Vouillamoz, 2000, Antimicrobial Agents and Chemotherapy.

Experimental endocarditis following dental extractions in rats with periodontitis.

P. Moreillon, M. Glauser, C. Overholser, 1988, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

An epidemic of food-borne listeriosis in western Switzerland: description of 57 cases involving adults.

J. Billé, J Bille, M. Glauser, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibiotic Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis

U. Flúckiger, P. Moreillon, J. Entenza, 1994 .

Campylobacter fetus Subspecies fetus Bacteremia

P. Francioli, G. Mombelli, J. Herzstein, 1985 .

Role of complement-derived and bacterial formylpeptide chemotactic factors in the in vivo migration of neutrophils in experimental Escherichia coli pyelonephritis in rats.

P. Meylan, M. Glauser, 1989, The Journal of infectious diseases.

Antibiotic prophylaxis of experimental endocarditis after dental extractions.

J. Billé, R. Malinverni, M. Glauser, 1988, Circulation.

Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers

W. Kern, G. Klotz, R. Marre, 1996, Antimicrobial agents and chemotherapy.

Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans

D. Sanglard, J. Billé, O. Marchetti, 2000, Antimicrobial Agents and Chemotherapy.

Empiric therapy of bacterial infections in severe neutropenia

J. Palmblad, M. Boogaerts, C. Cordonnier, 1997 .

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperati

T. Calandra, C. Viscoli, H. Gaya, 1991, Antimicrobial Agents and Chemotherapy.

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Itali

M. Paesmans, T. Calandra, C. Viscoli, 1996, Antimicrobial agents and chemotherapy.

Deregulation of the Arginine Deiminase (arc) Operon in Penicillin-Tolerant Mutants ofStreptococcus gordonii

H. Langen, I. Caldelari, P. Moreillon, 2000, Antimicrobial Agents and Chemotherapy.

Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.

O. Cornely, K. Tack, M. Glauser, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Efficacy and Toxicity of Single Daily Doses of Amikacin and Ceftriaxone versus Multiple Daily Doses of Amikacin and Ceftazidime for Infection in Patients with Cancer and Granulocytopenia

M. Paesmans, T. Calandra, C. Viscoli, 1993, Annals of Internal Medicine.

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel.

J. Karp, J. Verhoef, L. Young, 1990, The Journal of infectious diseases.

RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci

C. Leport, F. L’hériteau, P. Moreillon, 1995, Antimicrobial agents and chemotherapy.

Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring

P. Meylan, J. Billé, M. Glauser, 1989, Infection and immunity.

Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia.

J. Billé, M. Glauser, 1982, The Journal of infectious diseases.

Prospective Randomized Comparison of Imipenem-Cilastatin and Piperacillin-Tazobactam in Nosocomial Pneumonia or Peritonitis

R. Chioléro, C. Jaccard, S. Harbarth, 1998, Antimicrobial Agents and Chemotherapy.

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

M. Paesmans, T. Calandra, C. Viscoli, 1995, Antimicrobial agents and chemotherapy.

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

T. Calandra, H. Gaya, J. Klastersky, 1987, The New England journal of medicine.

Prophylaxis of infective endocarditis for dental procedures. Report of a working party of the European Society of Cardiology.

J. Etienne, L. Gruer, M. Glauser, 1985, European heart journal.

Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis

P. Francioli, U. Flúckiger, J. Entenza, 1993, Antimicrobial Agents and Chemotherapy.

Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study

M. Schaller, R. Chioléro, Gilbert GREUB, 2003, Antimicrobial Agents and Chemotherapy.

Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans

D. Sanglard, J. Billé, O. Marchetti, 2000, Antimicrobial Agents and Chemotherapy.

Prevention of acute and chronic ascending pyelonephritis in rats by aminoglycoside antibiotics accumulated and persistent in kidneys

J. Billé, M. Glauser, 1981, Antimicrobial Agents and Chemotherapy.

Synergism of ampicillin and gentamicin against obstructive pyelonephritis due to Escherichia coli in rats.

A. Braude, M. Glauser, J. Lyons, 1979, The Journal of infectious diseases.

Prevention of pyelonephritis due to Escherichia coli in rats with gentamicin stored in kidney tissue.

A. Braude, M. Glauser, J. Lyons, 1979, The Journal of infectious diseases.

Correlation between in vitro susceptibility ofCandida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients

J. Chave, J. Billé, C. Durussel, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

albicans Candida Experimental Endocarditis Due to Fungicidal Combination Effective against Fluconazole plus Cyclosporine : a

D. Sanglard, J. Billé, O. Marchetti, 2000 .

Empirical treatment of fever in neutropenic children: The role of the carbapenems

C. Viscoli, D. Engelhard, E. Castagnola, 1996 .

Gram-positive bacteraemia in granulocytopenic cancer patients.

T. Calandra, C. Viscoli, H. Gaya, 1990, European journal of cancer.

Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500

H. Drugeon, P. Moreillon, J. Entenza, 1995, Antimicrobial agents and chemotherapy.

Prophylaxis of pyelonephritis by aminoglycosides accumulated in the kidney.

J. Billé, M. Glauser, 1981, The Journal of antimicrobial chemotherapy.

Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis

P. Moreillon, J. Entenza, J. Vouillamoz, 1996, Antimicrobial agents and chemotherapy.

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

P. Francioli, R. Chioléro, T. Calandra, 1999, Critical care medicine.

Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1 Genes

D. Sanglard, J. Billé, O. Marchetti, 2003, Antimicrobial Agents and Chemotherapy.

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.

M. Paesmans, T. Calandra, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.

P. Morel, W. Zimmerli, S. Harbarth, 1999, International journal of antimicrobial agents.

Study of Staphylococcus aureusPathogenic Genes by Transfer and Expression in the Less Virulent Organism Streptococcus gordonii

P. Francioli, P. Vaudaux, P. Moreillon, 2001, Infection and Immunity.

Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.

M. Tattersall, T. Calandra, C. Viscoli, 1988, European journal of cancer & clinical oncology.

Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.

M. Paesmans, C. Viscoli, J. Klastersky, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of immunoglobulins in prevention and treatment of infection in critically ill patients: review and critique.

J. Baumgartner, M. Glauser, G. Zanetti, 1991, Reviews of infectious diseases.

Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for european patients with acquired immunodeficiency syndrome

B. Clotet, C. Katlama, J. Gatell, 1995 .

Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.

U. Flúckiger, P. Moreillon, J. Entenza, 1995, The Journal of infectious diseases.

Teichoic Acids Are Not Required for Streptococcus pneumoniae and Staphylococcus aureus Cell Walls To Trigger the Release of Tumor Necrosis Factor by Peripheral Blood Monocytes

D. Heumann, P. Majcherczyk, P. Moreillon, 2003, Infection and Immunity.

Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Endocarditis during Staphylococcus aureus septicemia in a population of non-drug addicts.

M. Glauser, R. Mirimanoff, 1982, Archives of internal medicine.

Experimental Escherichia coli endocarditis in rats: roles of serum bactericidal activity and duration of catheter placement

B. Yersin, P. Guze, L. B. Guze, 1988, Infection and immunity.

Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide.

F. Steinhäuslin, A. Munafo, J. Biollaz, 1992, British journal of clinical pharmacology.

Asymptomatic oral yeast carriage in HIV-infected patients: frequency and fluconazole susceptibility profile.

J. Chave, J. Billé, C. Durussel, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.

J. Chave, J. Billé, C. Durussel, 1994, AIDS.

Empiric therapy of bacterial infections in patients with severe neutropenia.

M. Glauser, 1998, Diagnostic microbiology and infectious disease.

Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

M. Paesmans, T. Calandra, C. Viscoli, 1994, JAMA.

Natural history of aortic valve endocarditis in rats

M. Glauser, L. R. Freedman, E. Héraïef, 1982, Infection and immunity.

Chronic candida arthritis in leukemic patients.

M. Glauser, F. Delacrétaz, J. Gerster, 1982, Reviews of infectious diseases.

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

T. Calandra, J. Billé, A. Cometta, 1994, The New England journal of medicine.

Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.

M. Paesmans, T. Calandra, C. Viscoli, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies

M. Paesmans, C. Viscoli, H. Gaya, 1997, British journal of haematology.

Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius.

P. Francioli, P. Meylan, P. Moreillon, 1986, The Journal of infectious diseases.

Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients

J. Chave, J. Billé, A. Sugar, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Pitfalls in Cefepime Titration from Human Plasma: Plasma- and Temperature-Related Drug Degradation In Vitro

P. Majcherczyk, D. Bugnon, P. Moreillon, 2002, Antimicrobial Agents and Chemotherapy.

TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI

J. McCutchan, J. Fierer, J. Sadoff, 1983 .

Efficacies of Moxifloxacin, Ciprofloxacin, and Vancomycin against Experimental Endocarditis Due to Methicillin-ResistantStaphylococcus aureus Expressing Various Degrees of Ciprofloxacin Resistance

Y. Que, P. Moreillon, J. Entenza, 2001, Antimicrobial Agents and Chemotherapy.

Efﬁcacies of Moxiﬂoxacin, Ciproﬂoxacin, and Vancomycin against Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus Expressing Various Degrees of Ciproﬂoxacin Resistance

Y. Que, P. Moreillon, J. Entenza, 2001 .

Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus

P. Moreillon, J. Entenza, J. Vouillamoz, 1997, Antimicrobial agents and chemotherapy.

Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination

C. Perronne, R. Malinverni, M. Glauser, 1987, Antimicrobial Agents and Chemotherapy.

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

M. Ghannoum, R. Rubin, J. Solomkin, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin

P. Francioli, T. Calandra, F. Baudraz-Rosselet, 1985, European Journal of Clinical Microbiology.

Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography.

L. Decosterd, D. Sanglard, P. Majcherczyk, 2002, Journal of pharmaceutical and biomedical analysis.

Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group.

J. Billé, M. Glauser, 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing.

P. Francioli, J. Bernard, M. Glauser, 1981, The Journal of clinical investigation.

Sensitive Bioassay for Determination of Fluconazole Concentrations in Plasma Using a Candida albicans Mutant Hypersusceptible to Azoles

D. Sanglard, P. Majcherczyk, J. Billé, 2001, Antimicrobial Agents and Chemotherapy.

Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.

J. Chave, J. Pagani, J. Billé, 2002, The Journal of antimicrobial chemotherapy.

Erosive candida arthritis in a patient with disseminated candidiasis.

M. Glauser, F. Delacrétaz, J. Gerster, 1980, The Journal of rheumatology.

Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii.

P. Francioli, I. Caldelari, P. Moreillon, 1997, The Journal of infectious diseases.

Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics

P. Francioli, P. Meylan, M. Glauser, 1986, Antimicrobial Agents and Chemotherapy.

SEVERE CYTOMEGALOVIRUS INFECTION IN MULTIPLY TRANSFUSED, SPLENECTOMISED, TRAUMA PATIENTS

R. Chioléro, J. Baumgartner, N. Pyndiah, 1982, The Lancet.

Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study.

J. Chave, J. Billé, M. Glauser, 1989, The Journal of infectious diseases.

Gastric and duodenal bacterial colonization in HIV-infected patients without gastrointestinal symptoms.

J. Chave, M. Fried, J. Gonvers, 1994, The American journal of gastroenterology.

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

H. Gaya, J. Klastersky, S. Schimpff, 1986, Antimicrobial Agents and Chemotherapy.

[Familial paraproteinemia and lichen myxedematosus. II. Immunological study].

G. Maillard, M. Glauser, M. Emch, 1970, Schweizerische medizinische Wochenschrift.

[Familial paraproteinemia and lichen myxedematosus. I. Clinical study].

G. Maillard, M. Glauser, M. Emch, 1970, Schweizerische medizinische Wochenschrift.

Single-dose therapy for esophageal candidiasis with fluconazole.

P. Francioli, B. Hirschel, M. Glauser, 1990, AIDS.

Evaluation of the susceptibility of pathogenicCandida species to fluconazole

J. Billé, M. Glauser, Fluconazole Global Susceptibility Study Group, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Dual microsporidial infection due to Vittaforma corneae and Encephalitozoon hellem in a patient with AIDS.

E. Canning, A. Mathis, P. Deplazes, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of gallbladder lithiasis after ceftriaxone treatment.

J. Gonvers, L. Cantoni, A. Cometta, 1990, The Journal of antimicrobial chemotherapy.

Management of Infections in Immunocompromised Patients

P. Pizzo, M. Glauser, 2000 .

[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].

J. Baumgartner, A. Cometta, M. Glauser, 2000, Schweizerische medizinische Wochenschrift.

Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease.

P. Moreillon, R. Malinverni, M. Glauser, 1988, The Journal of infectious diseases.

BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis

P. Moreillon, J. Entenza, M. Glauser, 2002, Antimicrobial Agents and Chemotherapy.

Cephalosporin resistance in strains of Klebsiella oxytoca isolated during antibiotic therapy.

M. Arisawa, M. Glauser, R. Then, 1983, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious....

Epidemiology of cryptosporidiosis among European AIDS patients.

R. Weber, C. Katlama, A. Lazzarin, 1996, Genitourinary medicine.

Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection.

P. Francioli, P Francioli, J. Bernard, 1983, The Journal of infectious diseases.

Infection of a lumbar dermoid cyst by an anaerobic peptococcus

N. Tribolet, M. Glauser, J. Schnegg, 2005, Acta Neurochirurgica.

Comparative Studies of Fluoroquinolones in the Treatment of Urinary Tract Infections

R. Malinverni, M. Glauser, 1989 .

In-vitro activity of temafloxacin for gram-positive pathogens.

J. Billé, M. Glauser, 1991, The Journal of antimicrobial chemotherapy.

Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: role for cellular host defenses

B. Yersin, M. Glauser, L. R. Freedman, 1982, Infection and immunity.

Clinical experience with Timentin in severe hospital infections.

T. Calandra, P. Meylan, M. Glauser, 1986, The Journal of antimicrobial chemotherapy.

The inflammatory response and tissue damage

P. Meylan, J. Billé, M. Glauser, 1987, Pediatric Nephrology.

Prevention of chronic experimental pyelonephritis by suppression of acute suppuration.

J M Lyons, A. Braude, M. Glauser, 1978, The Journal of clinical investigation.

Immunotherapy of gram-negative infections in oncological patients.

M. Glauser, 1989, European journal of cancer & clinical oncology.

Effect of indomethacin on the incidence of experimental Escherichia coli pyelonephritis

P. Francioli, P. Meylan, J. Billé, 1983, Infection and immunity.

Failure of dexamethasone to prevent polymorphonuclear leukocyte infiltration during experimental acute exudative pyelonephritis and to reduce subsequent chronic scarring.

P. Meylan, M. Glauser, 1988, The Journal of infectious diseases.

Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis

P. Meylan, M. Glauser, G. Braoudakis, 1986, Antimicrobial Agents and Chemotherapy.

Treatment of experimental ascending Escherichia coli pyelonephritis with ceftriaxone alone and in combination with gentamicin.

M. Glauser, Bonard, 1982, Chemotherapy.

Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.

A. Cometta, M. Glauser, M P Glauser, 1996, Journal of chemotherapy.

An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.

P. Bruzzi, C. Viscoli, M. Glauser, 1995, European journal of cancer.

Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.

T. Calandra, F. Meunier, P. Eggimann, 1993, The Journal of antimicrobial chemotherapy.

Alterations of host defenses: the key to the multifaceted spectrum of infections in immunocompromised patients.

M. Glauser, 1991, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Comparative studies of fluoroquinolones in the treatment of urinary tract infections.

R. Malinverni, M. Glauser, 1988, Reviews of infectious diseases.

Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.

L. Cantoni, J. Billé, A. Wenger, 1989, The Journal of infectious diseases.

Efficacy of Trovafloxacin in Treatment of Experimental Staphylococcal or Streptococcal Endocarditis

P. Moreillon, J. Entenza, J. Vouillamoz, 1999, Antimicrobial Agents and Chemotherapy.

Treatment of Gram negative meningitis with cefotaxime.

N. de Tribolet, M. Glauser, R. Mirimanoff, 1983, Neurochirurgia.

Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study Group.

A. Phillips, A. Lazzarin, J. Lundgren, 1996, Journal of clinical epidemiology.

Beta-2 microglobulin: A sensitive non-specific marker of acquired immune deficiency syndrome

P. Francioli, M. Glauser, F. Clément, 1984, European Journal of Clinical Microbiology.

Beta-2-microglobulin in acquired immune deficiency syndrome.

P. Francioli, B. Yersin, M. Glauser, 1984, Antibiotics and chemotherapy.

Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression

L. Perrin, B. Hirschel, A. Lazzarin, 1997 .

[Neurologic complications accompanying acquired immunodeficiency syndrome (AIDS): study of a group of 8 cases].

A. Steck, J. Chave, F. Regli, 1987, Schweizerische medizinische Wochenschrift.

The use of aminoglycosides in neutropenic patients.

A. Cometta, M. Glauser, 1996, Schweizerische medizinische Wochenschrift. Supplementum.

POST-EXPOSURE PROPHYLAXIS AGAINST HIV INFECTION IN HEALTH CARE WORKERS

P. Francioli, P. Meylan, M. Glauser, 1988, The Lancet.

Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats

T. Calandra, R. Malinverni, J. Entenza, 1992, Antimicrobial Agents and Chemotherapy.

Experimental bacterial endocarditis after dental extractions in rats with periodontitis.

P. Moreillon, M. Glauser, C. Overholser, 1987, The Journal of infectious diseases.

Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine

Anne M Johnson, Andrew N. Phillips, Reggio Emilia, 1994 .

Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination

L. Cantoni, J. Billé, M. Glauser, 1990, Antimicrobial Agents and Chemotherapy.

[Epidemic listeriosis. Report of 25 cases in 15 months at the Vaud University Hospital Center].

F. Regli, J. Billé, R. Malinverni, 1985, Schweizerische medizinische Wochenschrift.

Unusual clinical features of an epidemic of listeriosis associated with a particular phage type

J. Rocourt, J. Billé, R. Malinverni, 1986, European Journal of Clinical Microbiology.

8th European Congress of Clinical Microbiology and Infectious Diseases Lausanne, Switzerland, May 25--28, 1997.

M. Glauser, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci.

P. Francioli, U. Flúckiger, J. Blaser, 1994, The Journal of infectious diseases.

Efficacy of Garenoxacin in Treatment of Experimental Endocarditis Due to Staphylococcus aureus or Viridans Group Streptococci

P. Moreillon, J. Entenza, J. Vouillamoz, 2004, Antimicrobial Agents and Chemotherapy.

Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition

A. Munafo, J. Biollaz, P. Dayer, 1992, Antimicrobial Agents and Chemotherapy.

Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.

I. Caldelari, P. Moreillon, J. Entenza, 1999, The Journal of antimicrobial chemotherapy.

Cardiobacterium hominis endocarditis manifesting as bacterial meningitis.

P. Francioli, M. Glauser, D. Roussianos, 1983, Archives of internal medicine.

Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci

P. Moreillon, J. Entenza, M. Glauser, 1994, Antimicrobial Agents and Chemotherapy.

Y-688, a New Quinolone Active against Quinolone-Resistant Staphylococcus aureus: Lack of In Vivo Efficacy in Experimental Endocarditis

O. Marchetti, P. Moreillon, J. Entenza, 1998, Antimicrobial Agents and Chemotherapy.

Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats

P. Francioli, M. Bickle, U. Flúckiger, 1994, Antimicrobial Agents and Chemotherapy.

ANTIBIOTIC PROPHYLAXIS FOR PATIENTS WITH PROSTHETIC VALVES

P. Francioli, H. O'connor, P. Moreillon, 1983, The Lancet.

Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.

F. Goebel, A. Johnson, C. Pedersen, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics.

P. Francioli, M. Glauser, 1982, The Journal of infectious diseases.

The value of experimental models in the prophylaxis of bacterial endocarditis

R. Malinverni, M. Glauser, 1987 .

Comparison of single and multiple doses of prophylactic antibiotics in experimental streptococcal endocarditis.

P. Francioli, R. Malinverni, M. Glauser, 1987, Circulation.

Single-dose rifampin prophylaxis for experimental endocarditis induced by high bacterial inocula of viridans streptococci.

J. Billé, R. Malinverni, M. Glauser, 1987, The Journal of infectious diseases.

Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci.

P. Francioli, P. Moreillon, M. Glauser, 1985, The Journal of infectious diseases.

Successful prophylaxis of experimental streptococcal endocarditis with single doses of sublethal concentrations of penicillin.

P. Francioli, M. Glauser, 1985, The Journal of antimicrobial chemotherapy.